JNJ vs BIIB
By Alex · Tickerpine
Johnson & Johnson vs Biogen Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | BIIB |
|---|---|---|
| Price | $254.66 | $216.03 |
| Market cap | $613.02B | $31.89B |
| P/E ratio | 29.5 | 23.3 |
| ROE | 26.42% | 7.70% |
| Profit margin | 21.83% | 13.80% |
| Revenue growth | 9.90% | 1.90% |
| Dividend yield | 2.10% | — |
| Beta | 0.26 | 0.18 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs BIIB in plain English
- JNJ is the bigger company — about 19.2× the market cap of BIIB.
- BIIB is cheaper on earnings (P/E 23.3 vs 29.5).
- JNJ earns a higher return on equity (26% vs 8%).
- JNJ is growing revenue faster (10% vs 2%).
- JNJ pays a dividend (2.10%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
BIIB return calculator
See what $1,000 in Biogen Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.